Maternal Serum Alpha-fetoprotein Level May Predict the Presence of Morbid Adherent Placenta

Alpha-fetoprotein as a Biochemical Marker in Prediction of Placenta Acreta Increta Percreta

The aim of the study is to compare between alpha-fetoproteine as a biological marker and between ultrasound and Doppler in prediction of morbid adherent placenta.

in pregnant women withe previous cesarean section, placenta previa and ultrasonographic finding of an abnormally adherent placenta dose maternal serum alpha-fetoprotein predict prenataly the presence of morbid adherent placenta accurately?

Inclusion Criteria:

• pregnant women with history of scarred uterus

  • plcenta previa covering the scar of previous caesarean section as diagnosed by 2DU/S
  • Gestational age from 28wks to full term

Exclusion Criteria:

• pregnant women with fetus with congenital anomalies

  • pregnant women with ovarian swelling
  • pregnant women with medical disease